{"member_organisations": "", "identification_number": "407166332082-15", "fields_of_interest": "Trade, Research and innovation, Public Health", "head_office_address": "Quay House 28 Parkway Deeside Industrial Park", "full_time_equivalent_fte": "1,25", "person_with_legal_responsibility": "Maireadh Pedersen", "industry_forums": "", "grants": "2299", "inter_groups": "", "eu_initiatives": "Quay Pharmaceuticals will be meeting with various EU Institutions and agencies to seek clarity on EU initiatives, policies and legislation relating to their project. This will include issues surrounding biotherapeutic approaches and GMP facilities addressed in the EU\u2019s bioeconomy strategy, Europe 2020 and the Innovation Union.", "level_of_interest": "global", "organisation_name": "Quay Pharmaceuticals Limited", "belgium_office_post_code": "", "number_of_persons_involved": "4", "person_in_charge_of_eu_relations": "Maireadh Pedersen", "section": "II - In-house lobbyists and trade/business/professional associations", "source": "", "subsection": "Companies & groups", "belgium_office_phone": "", "overall_budget_turnover_as_a_range": "", "belgium_office_address": "", "no_geo_reference": true, "persons_accredited_for_access_to_european_parliament_premises": "", "registration_date": "17/07/2018", "estimate_of_costs_absolute_amount": "", "website_address": "http://www.quaypharma.com", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "Deeside", "membership": "Bionow  - www.bionow.co.uk \n \nBiocom - www.biocom.org \n \nPharmabiotic - www.pharmabiotic.org \n \nBCMPA - www.bcmpa.org.uk \n \nBIA \u2013 www.bioindustry.org", "head_office_post_code": "CH5 2NS", "position": "CEO", "financial_year_start_date": "01/06/2017", "head_office_country": "United Kingdom", "number_of_ep_accredited_persons": "", "relevant_communication": "Not applicable", "financial_year_end_date": "01/05/2018", "estimate_of_costs_as_a_range": "100000-199999", "overall_budget_turnover_absolute_amount": "0", "legal_status": "Private Limited", "procurement": "", "customers": "", "belgium_office_post_box": "", "goals__remit": "Quay Pharmaceuticals is a Contract Development and Manufacturing Organisation providing a comprehensive out-sourcing service for formulation, analytical development and clinical trials manufacturing for pharmaceutical and biotechnology companies world-wide. We apply strong project management and technical expertise to take new products quickly and cost effectively from late stage pre-clinical through to the end of phase III clinical trials and supporting initial commercial supplies. We have built a reputation for specialising in the formulation of New Chemical Entities that exhibit poor solubility and bio-availability and for novel formulation of biologicals for oral delivery. Building on this expertise Quay has expanded it\u2019s offering into the live biotherapeutics area helping companies exploit the potential of using the body\u2019s natural microbiome to treat or prevent the development of disease. Quay are currently the only service provider who is licensed by both the MHRA and FDA for the clinical manufacture of live biotherapeutics.", "belgium_office_city": "", "head_office_phone": "(+44)01244837000"}